United States Emergency Department Use of Medications with Pharmacogenetic Recommendations

Introduction: Emergency departments (ED) use many medications with a range of therapeutic efficacy and potential significant side effects, and many medications have dosage adjustment recommendations based on the patient’s specific genotype. How frequently medications with such pharmaco-genetic recom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexander T. Limkakeng Jr, Pratik Manandhar, Alaatin Erkanli, Stephanie A. Eucker, Adam Root, Deepak Voora
Formato: article
Lenguaje:EN
Publicado: eScholarship Publishing, University of California 2021
Materias:
R
Acceso en línea:https://doaj.org/article/8b9ecebb93ef46e1b446e8581b791de3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b9ecebb93ef46e1b446e8581b791de3
record_format dspace
spelling oai:doaj.org-article:8b9ecebb93ef46e1b446e8581b791de32021-11-17T15:19:27ZUnited States Emergency Department Use of Medications with Pharmacogenetic Recommendations1936-901810.5811/westjem.2021.5.51248https://doaj.org/article/8b9ecebb93ef46e1b446e8581b791de32021-09-01T00:00:00Zhttps://escholarship.org/uc/item/4wx1n4gfhttps://doaj.org/toc/1936-9018Introduction: Emergency departments (ED) use many medications with a range of therapeutic efficacy and potential significant side effects, and many medications have dosage adjustment recommendations based on the patient’s specific genotype. How frequently medications with such pharmaco-genetic recommendations are used in United States (US) EDs has not been studied. Methods: We conducted a cross-sectional analysis of the 2010–2015 National Hospital Ambulatory Medical Care Survey (NHAMCS). We reported the proportion of ED visits in which at least one medication with Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendation of Level A or B evidence was ordered. Secondary comparisons included distributions and 95% confidence intervals of age, gender, race/ethnicity, ED disposition, geographical region, immediacy, and insurance status between all ED visits and those involving a CPIC medication. Results: From 165,155 entries representing 805,726,000 US ED visits in the 2010–2015 NHAMCS, 148,243,000 ED visits (18.4%) led to orders of CPIC medications. The most common CPIC medication was tramadol (6.3%). Visits involving CPIC medications had higher proportions of patients who were female, had private insurance and self-pay, and were discharged from the ED. They also involved lower proportions of patients with Medicare and Medicaid. Conclusion: Almost one fifth of US ED visits involve a medication with a pharmacogenetic recommendation that may impact the efficacy and toxicity for individual patients. While direct application of genotyping is still in development, it is important for emergency care providers to understand and support this technology given its potential to improve individualized, patient-centered care.Alexander T. Limkakeng JrPratik ManandharAlaatin ErkanliStephanie A. EuckerAdam RootDeepak VooraeScholarship Publishing, University of CaliforniaarticleMedicineRMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENWestern Journal of Emergency Medicine, Vol 22, Iss 6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Medicine
R
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Alexander T. Limkakeng Jr
Pratik Manandhar
Alaatin Erkanli
Stephanie A. Eucker
Adam Root
Deepak Voora
United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
description Introduction: Emergency departments (ED) use many medications with a range of therapeutic efficacy and potential significant side effects, and many medications have dosage adjustment recommendations based on the patient’s specific genotype. How frequently medications with such pharmaco-genetic recommendations are used in United States (US) EDs has not been studied. Methods: We conducted a cross-sectional analysis of the 2010–2015 National Hospital Ambulatory Medical Care Survey (NHAMCS). We reported the proportion of ED visits in which at least one medication with Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendation of Level A or B evidence was ordered. Secondary comparisons included distributions and 95% confidence intervals of age, gender, race/ethnicity, ED disposition, geographical region, immediacy, and insurance status between all ED visits and those involving a CPIC medication. Results: From 165,155 entries representing 805,726,000 US ED visits in the 2010–2015 NHAMCS, 148,243,000 ED visits (18.4%) led to orders of CPIC medications. The most common CPIC medication was tramadol (6.3%). Visits involving CPIC medications had higher proportions of patients who were female, had private insurance and self-pay, and were discharged from the ED. They also involved lower proportions of patients with Medicare and Medicaid. Conclusion: Almost one fifth of US ED visits involve a medication with a pharmacogenetic recommendation that may impact the efficacy and toxicity for individual patients. While direct application of genotyping is still in development, it is important for emergency care providers to understand and support this technology given its potential to improve individualized, patient-centered care.
format article
author Alexander T. Limkakeng Jr
Pratik Manandhar
Alaatin Erkanli
Stephanie A. Eucker
Adam Root
Deepak Voora
author_facet Alexander T. Limkakeng Jr
Pratik Manandhar
Alaatin Erkanli
Stephanie A. Eucker
Adam Root
Deepak Voora
author_sort Alexander T. Limkakeng Jr
title United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
title_short United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
title_full United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
title_fullStr United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
title_full_unstemmed United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
title_sort united states emergency department use of medications with pharmacogenetic recommendations
publisher eScholarship Publishing, University of California
publishDate 2021
url https://doaj.org/article/8b9ecebb93ef46e1b446e8581b791de3
work_keys_str_mv AT alexandertlimkakengjr unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
AT pratikmanandhar unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
AT alaatinerkanli unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
AT stephanieaeucker unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
AT adamroot unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
AT deepakvoora unitedstatesemergencydepartmentuseofmedicationswithpharmacogeneticrecommendations
_version_ 1718425428113227776